[250 Pages Report] The Hemostats For Wound Closure Market expected to register a CAGR of 6.3% during the forecast period, up from USD 2.4 Billion in 2021 to reach a valuation of USD 3.5 Billion by 2026.
| Report Attributes | Details |
|---|---|
| Estimated Base Year Value (2021) | USD 2.4 Billion |
| Expected Market Value (2026) | USD 3.5 Billion |
| Projected Growth Rate (2022 to 2032) | 6.3% |
Sales of hemostats for wound closure are expected to rise as the number of surgical procedures performed is increasing. In addition to this, demand for hemostats for wound closure is rising on account of sports-related injuries and spinal problems becoming more common.
Increasing investments in research and development areas are also projected to contribute to the growth of the hemostats for wound closure market share.
The report sheds light on the factors improving the sales of hemostats for wound closure, and, in turn, the opportunities for the market players. However, the hemostats for wound closure market also faces some challenges, which might limit the hemostats for wound closure market share from reaching its potential.
Some of the key hemostats for wound closure market trends promoting the demand for hemostats for wound closure is rising due to rise in the number of hospitals and surgical centers in developing countries. Due to the growing patient population, surgical equipment (including medical devices such as hemostats) is in great demand in these newly constructed surgical centers and hospitals.
Developing countries like India and China have seen tremendous advancements in their healthcare infrastructure over the previous decade. The hemostats for wound closure market likely to benefit from the large increase in the number of hospitals and surgical centers, as these are the primary end consumers of hemostats.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Topical hemostatic agents and tissue adhesives are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
Wound closure has become a very frequent clinical practice that is growing very rapidly. The sophisticated procedures ensure the rapid cessation of blood loss, prompt closure, strong adhesion of wound edges, tight sealing, reduced scarring, reduced risk of infection, and more rapid healing.
There is a pool of patients throughout the world which makes the market for this product very lucrative. As the price is also very reasonable so the sales of hemostats for wound closure of the product are gradually progressing
On the other hand, some reports come which could restrict the demand for hemostats for wound closure.
Surgical staples are emerging as the most useful tool in this wound closure segment. A few reports also suggested that patients may suffer from irritation, heat inflammation or redness on the skin when hemostats are applied, though it's not clear the exact reason for these which might restrict the sales of hemostats for wound closure.
As the demand for hemostats for wound closure growing and price is low, tough competition will prevail in the segment.
With the rapid technological advancement in healthcare industry the sales of hemostats for wound closure expected to grow at a healthy CAGR in the forecasted period
Geographically, the hemostats for wound closure market have been segmented into seven major geographical regions which include North America, Eastern Europe, Western Europe, the Asia Pacific excluding Japan, Japan & Latin America, Middle East & Africa with rising global demand for hemostats for wound closure.
North America contributes the most in the sales of hemostats for wound closure followed by Europe. With the new product approvals, a change in regulatory policies encourages patient acceptance and helps the demand for hemostats for wound closure to grow. Asia Pacific & Japan pose good growth potential too for the rising sales of hemostats for wound closure.
Principal Consultant
Hemostats for wound closure market is highly fragmented with presence of big & small companies. The market leaders in this area are Johnson & Johnson, Covidien, B. Braun, and 3M.
To combat the high demand for hemostats for wound closure, Teleflex expanded its product portfolio in 2020 by acquiring Z-Medica, LLC (USA), a privately held medical device firm that manufactures and sells hemostatic (hemorrhage control) products under the QuikClot Combat Gauze and QuikClot Control+ brand names.
| Report Attributes | Details |
|---|---|
| Growth rate | CAGR of 6.3% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | B. Braun; Johnson & Johnson; 3M; Covidien. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The hemostats for wound closure market is predicted to register a CAGR of 6.3% during the forecast period.
Key players holding substantial hemostats for wound closure market share include B. Braun, Johnson & Johnson, 3M, and Covidien.
As per the analysis, the hemostats for wound closure market share is likely to be USD 3.5 Billion by 2026.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type 5.1. Thrombin Based Hemostats 5.2. Combination Hemostats 5.3. Oxidized Regenerated Hemostats 5.4. Cellulose Based Hemostats 5.5. Gelatin Based Hemostats 5.6. Collagen Based Hemostats 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Hospitals 6.2. Ambulatory Surgical Centers 6.3. Specialty Clinics 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. East Asia 7.5. South Asia & Pacific 7.6. MEA 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14. Key Countries Market Analysis 15. Market Structure Analysis 16. Competition Analysis 16.1. Johnson & Johnson Services, Inc. 16.2. Baxter 16.3. B. Braun Melsungen AG 16.4. Pfizer Inc. 16.5. Integra LifeSciences 16.6. Advanced Medical Solutions Group plc. 16.7. C. R. Bard, Inc. 16.8. Cresilon 16.9. Medtronic 16.10. Tissuemed Ltd 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Healthcare Insights
View Reports
Hemostats For Wound Closure Market
